A Multiple Ascending Dose Study of COR388

Clinical trial NCT03418688 · COMPLETED

Trial details

NCT number: NCT03418688
Sponsor: Cortexyme Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2018-03-06
Primary completion: 2018-10-15
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.